Rapamycin has a biphasic effect on insulin sensitivity in C2C12 myotubes due to sequential disruption of mTORC1 and mTORC2

Rapamycin, an inhibitor of mTOR complex 1 (mTORC1), improves insulin sensitivity in acute studies in vitro and in vivo by disrupting a negative feedback loop mediated by S6 kinase. We find that rapamycin has a clear biphasic effect on insulin sensitivity in C2C12 myotubes, with enhanced responsivene...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Lan, Varamini, Behzad, Lamming, Dudley W., Sabatini, David M., Baur, Joseph A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2012
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438685/
https://www.ncbi.nlm.nih.gov/pubmed/22973301
http://dx.doi.org/10.3389/fgene.2012.00177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438685/
https://www.ncbi.nlm.nih.gov/pubmed/22973301
http://dx.doi.org/10.3389/fgene.2012.00177

Ejemplares similares